CY 208-243

CY 208-243 Struktur
100999-26-6
CAS-Nr.
100999-26-6
Englisch Name:
CY 208-243
Synonyma:
CY 208-243;CY 208243,CY 208 243;(6aR)-4,6,6aα,7,8,12bβ-Hexahydro-7-methylindolo[4,3-ab]phenanthridine;(6aα,12bβ)-4,6,6a,7,8,12b-Hexahydro-7-methylindolo[4,3-ab]phenanthridine;(6aR,12bβ)-4,6,6a,7,8,12b-Hexahydro-7-methylindolo[4,3-ab]phenanthridine;(-)-(6AR,12BR)-4,6,6A,7,8,12B-HEXAHYDRO-7-METHYLINDOLO[4,3-A]PHENANTHRIDIN;(-)-(6aR,12bR)-4,6,6a,7,8,12β-Hexahydro-7-methylindolo[4,3-a]phenanthridin;[6aR,12bR,(-)]-4,6,6a,7,8,12b-Hexahydro-7-methylindolo[4,3-ab]phenanthridine;Indolo[4,3-ab]phenanthridine, 4,6,6a,7,8,12b-hexahydro-7-methyl-, (6aR,12bR)-
CBNumber:
CB0461748
Summenformel:
C19H18N2
Molgewicht:
274.36
MOL-Datei:
100999-26-6.mol

CY 208-243 Eigenschaften

Siedepunkt:
466.5±33.0 °C(Predicted)
Dichte
1.225±0.06 g/cm3(Predicted)
storage temp. 
Store at RT
Löslichkeit
Soluble to 100 mM in DMSO
Aggregatzustand
Powder
pka
17.40±0.20(Predicted)

Sicherheit

CY 208-243 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

CY 208-243 is a selective D1DR receptor agonist.

Biologische Aktivität

Centrally active dopamine D 1 receptor agonist, selective over D 2 receptor sites. Stimulates adenylate cyclase in rat striatal homogenates with an EC 50 of 125 nM. Unlike SKF 38393 ((?-1-Phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrobromide ), it exerts anti-Parkinsonian activity in animal models.

CY 208-243 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


CY 208-243 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 34)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Career Henan Chemica Co
+86-0371-86658258 15093356674;
laboratory@coreychem.com China 30255 58
3B Pharmachem (Wuhan) International Co.,Ltd. 821-50328103-801 18930552037
3bsc@sina.com China 15848 69
EMMX Biotechnology LLC 888-539-0666
info@emmx.com United States 8449 60
BOC Sciences --
info@bocsci.com USA 0 65
Energy Chemical 021-58432009 400-005-6266
marketing1@energy-chemical.com China 44894 58
MedBioPharmaceutical Technology Inc 021-69568360 18916172912
order@med-bio.cn China 8141 58
cjbscvictory 13348960310 13348960310
3003867561@qq.com China 9946 58
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 15801484223
psaitong@jm-bio.com China 29834 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24131 58

100999-26-6()Verwandte Suche:


  • (-)-(6AR,12BR)-4,6,6A,7,8,12B-HEXAHYDRO-7-METHYLINDOLO[4,3-A]PHENANTHRIDIN
  • (6aR)-4,6,6aα,7,8,12bβ-Hexahydro-7-methylindolo[4,3-ab]phenanthridine
  • (6aR,12bβ)-4,6,6a,7,8,12b-Hexahydro-7-methylindolo[4,3-ab]phenanthridine
  • (6aα,12bβ)-4,6,6a,7,8,12b-Hexahydro-7-methylindolo[4,3-ab]phenanthridine
  • [6aR,12bR,(-)]-4,6,6a,7,8,12b-Hexahydro-7-methylindolo[4,3-ab]phenanthridine
  • (-)-(6aR,12bR)-4,6,6a,7,8,12β-Hexahydro-7-methylindolo[4,3-a]phenanthridin
  • CY 208-243
  • Indolo[4,3-ab]phenanthridine, 4,6,6a,7,8,12b-hexahydro-7-methyl-, (6aR,12bR)-
  • CY 208243,CY 208 243
  • 100999-26-6
  • Dopamine receptor
Copyright 2019 © ChemicalBook. All rights reserved